Literature DB >> 18433344

The Caco-2 cell monolayer: usefulness and limitations.

Huadong Sun1, Edwin Cy Chow, Shanjun Liu, Yimin Du, K Sandy Pang.   

Abstract

BACKGROUND: The Caco-2 monolayer has been used extensively for the high-throughput screening of drug permeability and identification of substrates, inhibitors, and inducers of intestinal transporters, especially P-glycoprotein (P-gp). Traditionally, the Caco-2 monolayer is viewed as a single barrier rather than a polarized cell monolayer consisting of metabolic enzymes that are sandwiched between two membrane barriers with distinctly different transporters.
OBJECTIVE: This review addressed the usefulness and limitations of the Caco-2 cell monolayer in drug discovery and mechanistic studies.
METHODS: This mini-review covered applications of the Caco-2 monolayer, clarified misconceptions, and critically addressed issues on data interpretation.
CONCLUSION: The catenary model extends the usefulness of Caco-2 monolayer and provides proper mechanistic insight and data interpretation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18433344     DOI: 10.1517/17425255.4.4.395

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  84 in total

Review 1.  Getting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism.

Authors:  Paul A Dawson; Melissa L Hubbert; Anuradha Rao
Journal:  Biochim Biophys Acta       Date:  2010-06-09

2.  Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements.

Authors:  Caroline A Larregieu; Leslie Z Benet
Journal:  AAPS J       Date:  2013-01-24       Impact factor: 4.009

3.  Improvement of paracellular transport in the Caco-2 drug screening model using protein-engineered substrates.

Authors:  Rebecca L DiMarco; Daniel R Hunt; Ruby E Dewi; Sarah C Heilshorn
Journal:  Biomaterials       Date:  2017-03-18       Impact factor: 12.479

4.  Role of nanoparticle size, shape and surface chemistry in oral drug delivery.

Authors:  Amrita Banerjee; Jianping Qi; Rohan Gogoi; Jessica Wong; Samir Mitragotri
Journal:  J Control Release       Date:  2016-07-30       Impact factor: 9.776

Review 5.  The "Leaky Gut": Tight Junctions but Loose Associations?

Authors:  Daniel Hollander; Jonathan D Kaunitz
Journal:  Dig Dis Sci       Date:  2020-05       Impact factor: 3.199

6.  EspH Suppresses Erk by Spatial Segregation from CD81 Tetraspanin Microdomains.

Authors:  Rachana Pattani Ramachandran; Felipe Vences-Catalán; Dan Wiseman; Efrat Zlotkin-Rivkin; Eyal Shteyer; Naomi Melamed-Book; Ilan Rosenshine; Shoshana Levy; Benjamin Aroeti
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

7.  NR2F1 and IRE1beta suppress microsomal triglyceride transfer protein expression and lipoprotein assembly in undifferentiated intestinal epithelial cells.

Authors:  Kezhi Dai; Irani Khatun; M Mahmood Hussain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-12-10       Impact factor: 8.311

8.  A Monolayer of Primary Colonic Epithelium Generated on a Scaffold with a Gradient of Stiffness for Drug Transport Studies.

Authors:  Dulan B Gunasekara; Jennifer Speer; Yuli Wang; Daniel L Nguyen; Mark I Reed; Nicole M Smiddy; Joel S Parker; John K Fallon; Philip C Smith; Christopher E Sims; Scott T Magness; Nancy L Allbritton
Journal:  Anal Chem       Date:  2018-10-30       Impact factor: 6.986

9.  Group A streptococcal cysteine protease cleaves epithelial junctions and contributes to bacterial translocation.

Authors:  Tomoko Sumitomo; Masanobu Nakata; Miharu Higashino; Yutaka Terao; Shigetada Kawabata
Journal:  J Biol Chem       Date:  2013-03-26       Impact factor: 5.157

10.  Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoprotein.

Authors:  Mouna Kanaan; Youssef Daali; Pierre Dayer; Jules Desmeules
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-05-26       Impact factor: 4.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.